These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22021505)

  • 1. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.
    Akita H; Jinzaki M; Kikuchi E; Sugiura H; Akita A; Mikami S; Kuribayashi S
    AJR Am J Roentgenol; 2011 Nov; 197(5):1130-6. PubMed ID: 22021505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of adding diffusion-weighted images for tumor detection and preoperative staging in renal pelvic carcinoma for the reader's experience.
    Yoshida R; Yoshizako T; Maruyama M; Mori H; Ishikawa N; Tamaki Y; Kitagaki H
    Abdom Radiol (NY); 2017 Sep; 42(9):2297-2304. PubMed ID: 28352951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
    Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS
    AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
    Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
    J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?
    Watanabe H; Kanematsu M; Kondo H; Goshima S; Tsuge Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2009 May; 192(5):1361-6. PubMed ID: 19380561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
    Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
    AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
    Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
    J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer.
    Yoshida S; Masuda H; Ishii C; Tanaka H; Fujii Y; Kawakami S; Kihara K
    AJR Am J Roentgenol; 2011 Jan; 196(1):110-6. PubMed ID: 21178054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
    Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
    Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
    Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
    AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study.
    Low RN; Sebrechts CP; Barone RM; Muller W
    AJR Am J Roentgenol; 2009 Aug; 193(2):461-70. PubMed ID: 19620444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
    Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
    AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
    Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
    AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.